I recorded the audio and Rohan said they've filed for IP protection for two CNS candidates. He said they have a focus on autophagy production (a pathway in neurogenerative diseases) and neuroinflammation. He referred to the gazumped target as progranulin. Deficiency of progranulin in the CNS causes neurodegeneration and neuroinflammation.
PYC, page-39
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
-0.010(8.33%) |
Mkt cap ! $513.2M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 11.0¢ | $383.6K | 3.159M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 169997 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 1549 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 169997 | 0.110 |
5 | 392419 | 0.105 |
10 | 839229 | 0.100 |
2 | 13721 | 0.099 |
4 | 170204 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 1549 | 1 |
0.120 | 1000000 | 2 |
0.125 | 49465 | 1 |
0.130 | 1225102 | 19 |
0.135 | 488212 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online